• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下咽恶性炎性肌纤维母细胞瘤,携带融合基因的3a/b变异体。

A malignant inflammatory myofibroblastic tumor of the hypopharynx harboring the 3a/b variants of the fusion gene.

作者信息

Muscarella Lucia Anna, Rossi Giulio, Trombetta Domenico, La Torre Annamaria, Di Candia Leonarda, Mengoli Maria Cecilia, Sparaneo Angelo, Fazio Vito Michele, Graziano Paolo

机构信息

Laboratory of Oncology, Scientific Institute for Research and Healthcare, Casa Sollievo della Sofferenza, I-71013 San Giovanni Rotondo, Italy.

Pathologic Anatomy Unit, University Hospital Policlinico, I-41124 Modena, Italy.

出版信息

Oncol Lett. 2017 Feb;13(2):593-598. doi: 10.3892/ol.2016.5504. Epub 2016 Dec 14.

DOI:10.3892/ol.2016.5504
PMID:28356934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5351184/
Abstract

Inflammatory myofibroblastic tumors (IMT) in the head and neck region are rare neoplasms that generally mimic benign/low-grade neoplasms. Overexpression of anaplastic lymphoma kinase () has been reported in 50% of IMT cases, secondary to activation by structural rearrangements in the gene, which results in a fusion protein with echinoderm microtubule associated protein like 4 () in ~20% of cases. The present study describes a case of a 74-year-old woman with a malignant IMT in the right posterior hypopharynx harboring a previously unreported chromosomal rearrangement resulting in and gene fusion. Strong ALK immunoreactivity was observed in neoplastic cells, while fluorescent hybridization combined with fluorescent fragment analysis and direct sequencing identified the first case of the 3a/b variants of the fusion gene in IMT. The results of the current study highlight the uncommon occurrence of ALK-positive IMT in the head/neck region and demonstrate the importance of integrating different molecular methodologies to identify unequivocal gene fusion characterization.

摘要

头颈部炎性肌纤维母细胞瘤(IMT)是一种罕见肿瘤,通常类似良性/低级别肿瘤。据报道,50%的IMT病例中存在间变性淋巴瘤激酶(ALK)过表达,这是由于ALK基因发生结构重排激活所致,约20%的病例会产生一种与棘皮动物微管相关蛋白样4(EML4)的融合蛋白。本研究描述了一例74岁女性患者,其右下咽恶性IMT存在一种此前未报道的染色体重排,导致ALK和EML4基因融合。在肿瘤细胞中观察到强烈的ALK免疫反应性,而荧光原位杂交结合荧光片段分析和直接测序确定了IMT中首例ALK-EML4融合基因的3a/b变体。本研究结果突出了头颈部ALK阳性IMT的罕见性,并证明了整合不同分子方法以明确基因融合特征的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fe/5351184/811321a1df09/ol-13-02-0593-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fe/5351184/9284a685b851/ol-13-02-0593-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fe/5351184/811321a1df09/ol-13-02-0593-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fe/5351184/9284a685b851/ol-13-02-0593-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7fe/5351184/811321a1df09/ol-13-02-0593-g01.jpg

相似文献

1
A malignant inflammatory myofibroblastic tumor of the hypopharynx harboring the 3a/b variants of the fusion gene.下咽恶性炎性肌纤维母细胞瘤,携带融合基因的3a/b变异体。
Oncol Lett. 2017 Feb;13(2):593-598. doi: 10.3892/ol.2016.5504. Epub 2016 Dec 14.
2
Pulmonary inflammatory myofibroblastic tumor harboring EML4-ALK fusion gene.肺炎性肌纤维母细胞瘤伴 EML4-ALK 融合基因。
Jpn J Clin Oncol. 2014 Jan;44(1):93-6. doi: 10.1093/jjco/hyt173. Epub 2013 Nov 24.
3
Case Report: Early Distant Metastatic Inflammatory Myofibroblastic Tumor Harboring Fusion Gene: Study of Two Typical Cases and Review of Literature.病例报告:携带融合基因的早期远处转移炎性肌纤维母细胞瘤:两例典型病例研究及文献复习
Front Med (Lausanne). 2022 Feb 24;9:826705. doi: 10.3389/fmed.2022.826705. eCollection 2022.
4
Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testing.反转录-聚合酶链反应、免疫组织化学和荧光原位杂交方法检测棘皮动物微管相关蛋白样 4-间变性淋巴瘤激酶融合阳性非小细胞肺癌的比较:对最佳临床检测的影响。
Arch Pathol Lab Med. 2012 Jul;136(7):796-803. doi: 10.5858/arpa.2011-0321-OA.
5
Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants.根据ALK融合变体的间变性淋巴瘤激酶(ALK)重排肺腺癌的临床结局
J Transl Med. 2016 Oct 19;14(1):296. doi: 10.1186/s12967-016-1061-z.
6
Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement.具有频繁间变性淋巴瘤激酶(ALK)和ROS1基因融合以及罕见新型RET重排的炎性肌纤维母细胞瘤的分子特征
Am J Surg Pathol. 2015 Jul;39(7):957-67. doi: 10.1097/PAS.0000000000000404.
7
Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1-ALK fusion: a case report.头颈部炎性肌纤维母细胞瘤中新型 SQSTM1-ALK 融合导致对 ALK 抑制剂阿来替尼产生持久反应:一例报告。
Invest New Drugs. 2019 Aug;37(4):791-795. doi: 10.1007/s10637-019-00742-2. Epub 2019 Feb 21.
8
A new human lung adenocarcinoma cell line harboring the EML4-ALK fusion gene.携带有 EML4-ALK 融合基因的新型人肺腺癌细胞系。
Jpn J Clin Oncol. 2014 Oct;44(10):963-8. doi: 10.1093/jjco/hyu110. Epub 2014 Aug 28.
9
Expanding the Molecular Characterization of Thoracic Inflammatory Myofibroblastic Tumors beyond ALK Gene Rearrangements.拓展胸炎性肌纤维母细胞瘤的分子特征研究,超越 ALK 基因重排。
J Thorac Oncol. 2019 May;14(5):825-834. doi: 10.1016/j.jtho.2018.12.003. Epub 2018 Dec 11.
10
A case report: Pathological complete response to neoadjuvant lorlatinib for Epithelioid inflammatory myofibroblastic sarcoma with EML4-ALK rearrangement.病例报告:新辅助洛拉替尼治疗伴有EML4-ALK重排的上皮样炎性肌纤维母细胞肉瘤的病理完全缓解。
Front Pharmacol. 2024 Jul 31;15:1401428. doi: 10.3389/fphar.2024.1401428. eCollection 2024.

引用本文的文献

1
Giant inflammatory myofibroblastic tumor of the hypopharynx: an unusual cause of acute upper airway obstruction in a 6-year-old child.下咽巨大炎性肌纤维母细胞瘤:一名6岁儿童急性上呼吸道梗阻的罕见病因。
World J Pediatr Surg. 2022 Feb 13;5(2):e000342. doi: 10.1136/wjps-2021-000342. eCollection 2022.
2
Case Report: Early Distant Metastatic Inflammatory Myofibroblastic Tumor Harboring Fusion Gene: Study of Two Typical Cases and Review of Literature.病例报告:携带融合基因的早期远处转移炎性肌纤维母细胞瘤:两例典型病例研究及文献复习
Front Med (Lausanne). 2022 Feb 24;9:826705. doi: 10.3389/fmed.2022.826705. eCollection 2022.
3

本文引用的文献

1
Inflammatory Myofibroblastic Tumors: Current Update.炎性肌纤维母细胞瘤:最新进展
Radiol Clin North Am. 2016 May;54(3):553-63. doi: 10.1016/j.rcl.2015.12.005. Epub 2016 Mar 12.
2
Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement.具有频繁间变性淋巴瘤激酶(ALK)和ROS1基因融合以及罕见新型RET重排的炎性肌纤维母细胞瘤的分子特征
Am J Surg Pathol. 2015 Jul;39(7):957-67. doi: 10.1097/PAS.0000000000000404.
3
Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions.
A clinical signature predicting the malignant transformation of inflammatory myofibroblastic tumor in the head and neck.
预测头颈部炎性肌纤维母细胞瘤恶性转化的临床特征。
Laryngoscope Investig Otolaryngol. 2022 Jan 22;7(1):145-152. doi: 10.1002/lio2.731. eCollection 2022 Feb.
炎性肌纤维母细胞瘤含有多种潜在可靶向的激酶融合。
Cancer Discov. 2014 Aug;4(8):889-95. doi: 10.1158/2159-8290.CD-14-0377. Epub 2014 May 29.
4
Fusion of dynactin 1 to anaplastic lymphoma kinase in inflammatory myofibroblastic tumor.dynactin 1 与间变性淋巴瘤激酶融合在炎性肌纤维母细胞瘤中。
Hum Pathol. 2012 Nov;43(11):2047-52. doi: 10.1016/j.humpath.2012.02.014. Epub 2012 Jun 1.
5
ALKoma: a cancer subtype with a shared target.ALKoma:具有共同靶点的癌症亚型。
Cancer Discov. 2012 Jun;2(6):495-502. doi: 10.1158/2159-8290.CD-12-0009. Epub 2012 May 21.
6
Differential diagnosis of inflammatory myofibroblastic tumour and low-grade myofibroblastic sarcoma: two case reports with a literature review.炎症性肌纤维母细胞瘤与低级别肌纤维母细胞肉瘤的鉴别诊断:两例报告并文献复习
J Int Med Res. 2011;39(1):311-20. doi: 10.1177/147323001103900134.
7
Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification.表达新型融合蛋白 PPFIBP1-ALK 的肺炎性肌纤维母细胞瘤:重新评估抗 ALK 免疫组化作为新型 ALK 融合鉴定工具。
Clin Cancer Res. 2011 May 15;17(10):3341-8. doi: 10.1158/1078-0432.CCR-11-0063. Epub 2011 Mar 23.
8
Exon scanning by reverse transcriptase-polymerase chain reaction for detection of known and novel EML4-ALK fusion variants in non-small cell lung cancer.通过逆转录聚合酶链反应进行外显子扫描以检测非小细胞肺癌中已知和新型的EML4-ALK融合变体
Cancer Genet. 2011 Jan;204(1):45-52. doi: 10.1016/j.cancergencyto.2010.08.024.
9
Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.上皮样炎性肌纤维母细胞肉瘤:一种具有核膜或核周 ALK 的侵袭性腹腔内炎性肌纤维母细胞瘤变体。
Am J Surg Pathol. 2011 Jan;35(1):135-44. doi: 10.1097/PAS.0b013e318200cfd5.
10
Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.克唑替尼治疗间变性淋巴瘤激酶重排的炎性肌纤维母细胞瘤。
N Engl J Med. 2010 Oct 28;363(18):1727-33. doi: 10.1056/NEJMoa1007056.